Caption Management, LLC Chimerix Inc Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $7,240 - $11,040	4,000 Added 57.14%	11,000 $21,000
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $9,380 - $37,380	7,000 New	7,000 $15,000
Q4 2021 Feb 11, 2022	SELL	$5.23 - $7.18 $290,233 - $398,446	-55,494 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $329,634 - $485,572	55,494 New	55,494 $344,000

1.89M

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $748M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.